In alignment with the government’s direction, the School of Biomedical Sciences of the Faculty of Medicine (the School) at The Chinese University of Hong Kong (CUHK) vows to play a more proactive role to promote the development of translational medicine through research areas like ‘Stem Cell Biology and Regenerative Medicine’ and devote more resources to nurturing biomedical talents.
The School is also expecting to step up its contribution to the ‘Guangdong-Hong Kong-Macao Bay Area Development’ and the joint development of the ‘Hong Kong-Shenzhen Innovation and Technology Park’ at the Lok Ma Chau Loop.
Translating scientific knowledge into applicationsThe Faculty of Medicine at CUHK officially formed the School of Biomedical Sciences in 2010 through amalgamating four former preclinical departments including Anatomy, Biochemistry (Medicine), Pharmacology and Physiology. Since then, the School has placed heavy emphasis on promoting multidisciplinary research, capacity building and talent training.
‘We are in the century of biomedical science. It not only enhances our understanding of human health and diseases, but is also the foundation of the future development and prosperity of our society. Academic institutions engaging in the related fields of studies must do more than just high-quality research; they must engage in the training of the next generation of researchers, particularly physician-scientists, and in translating scientific knowledge into applications,’ remarked Professor Lap-Chee Tsui, Founding President of The Academy of Sciences of Hong Kong.
‘The School will continue to play a leading and indispensable role, particularly in the promotion of “Translational Medicine” through research areas like “Stem Cell Biology and Regenerative Medicine” and “Brain and Mind”, to carry out new scientific research projects and transformation technology,’ added Prof Rocky S. Tuan, Vice-Chancellor and President of CUHK.
Thrive to become the world-leading biomedical hubSince the establishment of the School, the amount of research funding has increased by 200%. Overall, in the past two years, there were five research projects led by scholars from the School receiving HK$33 million from the Collaborative Research Fund of the Research Grants Council. The School has also identified several impact research cases and the number of papers published in high impact international journals such as Nature has also been on the rise.
Looking ahead, the School aims to increase the linkage with industry, particularly with the Hong Kong Science and Technology Parks Corporation, and participate actively in the development of biomedical sciences-related initiatives to be carried out by the government in the Guangdong-Hong Kong-Macao Bay Area.
‘Capitalising on our existing strengths and the developmental outlook, the School will further thrive and become one of the world-leading biomedical hubs, that commits to high-impact, collaborative and translational research as well as first-class training of biomedical talents,’ concluded Prof Wai-Yee Chan, Professor of Biomedical Sciences and Director of the School of Biomedical Sciences of the Faculty of Medicine at CUHK. MIMS
Public or private? Do Hong Kong patients have a choice?
More than saving lives: Here’s why the government should consider providing universal HPV vaccination
The top 7 industry insights into Hong Kong healthcare of 2017